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Abstract
Background: Type II DNA topoisomerases are essential, ubiquitous enzymes that act to relieve topological problems arising
in DNA from normal cellular activity. Their mechanism of action involves the ATP-dependent transport of one DNA duplex
through a transient break in a second DNA duplex; metal ions are essential for strand passage. Humans have two isoforms,
topoisomerase IIa and topoisomerase IIb, that have distinct roles in the cell. The C-terminal domain has been linked to
isoform specific differences in activity and DNA interaction.
Methodology/Principal Findings: We have investigated the role of the C-terminal domain in the binding of human
topoisomerase IIa and topoisomerase IIb to DNA in fluorescence anisotropy assays using full length and C-terminally
truncated enzymes. We find that the C-terminal domain of topoisomerase IIb but not topoisomerase IIa affects the binding
of the enzyme to the DNA. The presence of metal ions has no effect on DNA binding. Additionally, we have examined strand
passage of the full length and truncated enzymes in the presence of a number of supporting metal ions and find that there
is no difference in relative decatenation between isoforms. We find that calcium and manganese, in addition to magnesium,
can support strand passage by the human topoisomerase II enzymes.
Conclusions/Significance: The C-terminal domain of topoisomerase IIb, but not that of topoisomerase IIa, alters the
enzyme’s KD for DNA binding. This is consistent with previous data and may be related to the differential modes of action of
the two isoforms in vivo. We also show strand passage with different supporting metal ions for human topoisomerase IIa or
topoisomerase IIb, either full length or C-terminally truncated. They all show the same preferences, whereby Mg. Ca.Mn.
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Introduction
Type II DNA topoisomerases are ubiquitous enzymes that are
essential for cellular survival, acting to relieve torsional stress
arising in DNA from normal cellular activity such as replication
and transcription. Their mechanism of action involves the ATP-
dependent transport of one DNA duplex through a transient break
in a second DNA duplex. Humans have two isoforms, topoisom-
erase IIa and topoisomerase IIb, which are encoded on different
chromosomes and have distinct cellular roles. Human topoisom-
erase IIa is required for chromosome segregation, while
topoisomerase IIb plays a key role in the regulation of
transcription [1–6] and is crucial for the late stages of neuronal
development [7]. Topoisomerase IIa and IIb are 68% identical in
amino acid sequence and share a similar domain structure that is
comparable to other type II enzymes. They have an N-terminal
ATPase domain, a central core domain housing the active site
tyrosine required for DNA cleavage and a C-terminal domain that
becomes post-translationally modified. While the core domain
from type II topoisomerases from yeast and bacteria has been
crystallized and the structure solved, and the ATPase domain has
been crystallized from bacterial, yeast and human enzymes, the
structure of the C-terminal domain has not been determined,
though it has been suggested to form a beta propeller form. The
holoenzyme has not been crystallized, so its proposed structure is
reliant on cryo EM images. The domain structure of human
topoisomerase enzymes is outlined in Figure 1.
Eukaryotic type II topoisomerases are dimers that can introduce
two transient DNA breaks with a 4 bp stagger in a single DNA
duplex, producing a protein bound DNA double strand break or
gate. A second DNA duplex termed a ‘transported’ or ‘T’ segment
can be captured by the N-terminal domain of the protein, and
passed through this transient break in a ‘gate’ or ‘G’ segment. The
protein associated DNA break is subsequently resealed [8]. Two
DNA interaction surfaces have been proposed. Evidence for one
site, consisting of a pair of semicircular grooves on the B’ and A’
subdomains that are thought to bind to ‘G’ segment, has been
reported following footprinting experiments and structural work
[9–10]. The cleavage reaction is carried out via an active site
tyrosine residue located in the core of the enzyme, with the cleaved
‘G’ segment interacting with a helix turn helix (HTH) motif in the
CAP domain of the core [11]. In particular, the a4 ‘recognition
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helix’ has been shown to interact with substrate DNA [12]. A
recent crystal structure of S. cerevisiae topoisomerase II with DNA
showed that on binding the ‘G’ segment the enzyme induces a
150u bend in the DNA and undergoes large conformational
changes such that an essential metal ion is positioned near to the
reactive tyrosine ready for cleavage [13]. Additionally, a second
site has been proposed in the N-terminal half of the enzyme, which
could potentially interact with the ‘T’ segment, following the
discovery of a groove lined with arginines in the crystal structure of
E. coli GyrB [14].
Metal ions, in particular divalent cations, are essential in the
mechanism of topoisomerase II. Magnesium is required for
stabilising the interaction with ATP in the N-terminal domain.
The phosphodiester cleavage reaction by a tyrosine in the enzyme
core also requires divalent metal ions and thus metal ions are
required to support strand passage. Experiments with eukaryotic
D. Melanogaster topoisomerase II reported that only Mg2+ could
support strand passage, in contrast to subsequent work with E. coli
gyrase which showed that Mg2+, Ca2+, Mn2+ and Co2+ could all
support activity [15–16], thus the interaction with metal ions
differs in topoisomerase II isoforms from different species.
Three very conserved motifs (EDGSA, IMTDQ and PLRGK)
are important for type II topoisomerase function [17]. Altered
magnesium optima were seen in proteins mutated within these
motifs in human topoisomerase IIb and two possible binding sites
were proposed for the metal ion(s) needed for DNA cleavage [18].
Subsequently, a two metal ion mechanism analogous to DNA
polymerases was proposed for the cleavage reaction [15,18–19]. A
recent crystal structure of the central breakage reunion domain
from yeast with DNA in a cleavage competent conformation has
two metal ions present, but these are zinc not magnesium [20]. In
contrast other crystal structures of core domains of type II
topoisomerases show only one metal ion [21–22]. Work with
human topoisomerase IIa and human topoisomerase IIb indicated
that interactions with the second metal ion may enhance the
ability of topoisomerase IIb, but not topoisomerase IIa to cleave
DNA [23]. Whether one or two ions are needed for cleavage, and
which ions these are, requires further study. In addition to a
catalytic role, metal ions have also been reported to play a
structural role in type II topoisomerase [24–25].
Eukaryotic type II topoisomerases have been shown, in strand
passage experiments, to prefer supercoiled substrates over
relaxed ones, with selectivity for crossovers, both experimentally
via electron microscopy experiments, and in silico. Such
selectivity may represent a mechanism for topological recogni-
tion [26–28].
Relaxation of supercoiled plasmid DNA by topoisomerases
occurs via a strand passage reaction that can produce a series of
topoisomers, with differing levels of superhelicity. This pattern
may be either processive, in which case the protein stays on the
same DNA molecule to relax it further, or distributive, where the
enzyme moves onto another supercoiled DNA molecule after one
or more rounds of relaxation. Previously, it was reported that
topoisomerase IIa gave a more distributive pattern in relaxation
assays, while topoisomerase IIb gave a highly processive pattern
[29], consistent with subsequent work showing that topoisomerase
IIa and topoisomerase IIb interact differently with supercoiled
substrates. Topoisomerase IIa had a 10-fold preference for positive
over negative supercoils whereas topoisomerase IIb showed no
preference [30]. Experiments with C-terminal domain swapped
proteins suggested that this geometry sensing was linked to the C-
terminal domain of the enzymes [31]. Consistent with this,
experiments show topoisomerase II from Paramecium bursaria
chlorella virus (PBCV) or chlorella virus Marburg-1 (CVM-1),
whose N-terminal and core domains have high homology to
eukaryotic topoisomerase II but which naturally lack the C-
terminal domain, have no preference for positive or negative
supercoils in relaxation [32]. We have previously shown that the
C-terminal domain of human topoisomerase IIa and topoisom-
erase IIb affects levels of strand passage in vitro as well as levels of
cell growth in complementation analysis, and suggested that the
topoisomerase IIb C-terminal domain may act as a negative
regulator [33].
In this study we have examined the role of the C-terminal
domain in the topoisomerase II-DNA interaction using fluores-
cence anisotropy. We have also examined the role of divalent
metal ions in strand passage activity and in DNA binding. We find
that the strength of interaction of human topoisomerase IIb, but
not topoisomerase IIa, with a DNA substrate is significantly
increased in the absence of the C-terminal domain, suggesting that
the C-terminal domain of topoisomerase IIb acts as a negative
regulator. Additionally, we find that the supporting metal ion has
no impact on the binding of DNA. The strand passage reaction
with both human topoisomerase II enzymes can be supported by
Figure 1. Schematic showing the domains of full length and truncated topoisomerase II isoforms. ‘Y’ is the active site tyrosine, within the
winged helix domain.
doi:10.1371/journal.pone.0014693.g001
Topoisomerase II
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calcium and manganese ions in addition to magnesium ions, in
contrast to the reported activity of Drosophila topoisomerase II.
Materials and Methods
Materials
Oligonucleotides were purchased from MWG and had the
following sequence: forward – 59-CGCAATCTGACAATGCGCT-
CATCGTCATCCTCGCGACGCG-39, reverse – 59-CGCGTG-
CCGAGGATGACGATGAGCGCATTGTCAGATTGCG-39. kDNA
was purchased from TopoGEN (Columbus, OH).
Protein Preparation
Proteins were overexpressed and purified from S.cerevisiae
strain JEL1Dtop1 as described previously [34–35]. Full length
topoisomerase IIa was expressed from plasmid YEpWob6 [36]
and full length topoisomerase IIb was expressed from plasmid
YEphTOP2bKLM [37]. Truncated topoisomerase IIa and
truncated topoisomerase IIb were expressed from plasmids
YEphTOP2at(1242) and YEphTOP2bt(1263) respectively, as
we reported previously [33]. For anisotropy experiments,
proteins were dialysed into 50 mM Tris pH 8, 10% glycerol,
1 mM EDTA, 1 mM EGTA, 150 mM KCl with protease
inhibitors.
In vitro activity assays
Decatenation assays were performed as described previously
[35,38], using 400 ng kDNA. Reactions were performed in
‘relaxation buffer’ (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,
0.5 mM EDTA, 30 mg/mL bovine serum albumin (BSA), 1 mM
DTT, 100 mM KCl). To assess the impact of different metals,
10 mM MgCl2 was replaced by 10 mM CaCl2, 10 mM MnCl2,
10 mM NiCl2 or 10 mM CoSO4 as appropriate. In all cases
reaction products were quantified using TINA version 2.09d
densitometry software. The ratio of decatenated DNA to the total
DNA was measured in each case and compared to a control lane.
Statistical significance was assessed using a one-sample t-test
measuring variance from 100%, with p,0.05 considered
significant.
DNA-binding measurements using fluorescence
anisotropy
DNA binding capacity was determined with purified protein
and a hexachlorofluorescein (HEX) labelled 40 bp double
stranded DNA oligo using fluorescence anisotropy. Measure-
ments were carried out at 20uC using a SLM-Amnico 8100
spectrofluorometer (SLM-Amnico, Urbana, IL). The excitation
wavelength was 530 nm with an excitation slit width of 8 mm
and the emission wavelength was 570 nm with an emission slit
width of 3 mm. A 1 ml fluorescence cuvette was used with
excitation and emission paths each of 10 mm. Assays were
carried out in anisotropy buffer (50 mM Tris pH 8, 5% glycerol,
50 mM KCl, 1% Triton X-100) supplemented with 100 mg/ml
acetylated BSA, and topoisomerase II proteins were matched for
buffers and salt concentration. 1 mM HEX-labelled oligo was
added to the buffer and a baseline reading taken. Protein was
added and an average anisotropy of 12 readings over 99 seconds
measured for each titration point. 10 mM MgCl2 or 10 mM
CaCl2 was added to the buffer where described. A one-binding
site hyperbola was fitted to data and the Bmax and KD
calculated using GraphPad Prism 5. Statistical significance was
assessed using an unpaired, two tailed Student’s t-test, with
p,0.05 considered significant.
Results
The effect of the C-terminal domain on DNA binding
The binding of both full length and C-terminally truncated
human recombinant DNA topoisomerase IIa and b enzymes to
DNA was measured using fluorescence anisotropy, a method we
have previously used to assess binding between enzyme and a
40 bp oligo with an mAMSA binding site [35].
Fluorescence anisotropy can be used to measure the interaction
between two molecules and to derive a binding constant. The two
molecules used here are an oligonucleotide labelled with a
hexafluorescein tag and purified unlabelled recombinant human
type II topoisomerases. When a complex forms between the
oligonucleotide and protein it changes the environment of both
macromolecules, and alters the rate at which the molecules tumble
in solution. Excitation of the fluorophore by polarised light enables
it to emit polarised light of a different wavelength, but if the
molecule is tumbling free in solution the emitted light radiates in
different directions and the light signal is scrambled rather than
polarised. If the oligonucleotide bearing the fluorophore binds to a
protein it will tumble less, reducing the scrambling and enabling
more polarised light to be detected. When all the fluorophore is
bound to protein the binding curve plateaus indicating that the
maximum anisotropy or maximum binding (Bmax) has been
reached. Differences in Bmax indicate a difference in binding
mode, although specific mechanistic details cannot be inferred
from this data. The KD is the concentration of ligand required to
give half maximal binding. An example plot is shown in Figure 2a.
Measurements were determined as described in Materials and
Methods.
Four different proteins were used, full length topoisomerase IIa,
full length topoisomerase IIb, and each isoform without its C-
terminal domain, referred to as truncated topoisomerase IIa and
truncated topoisomerase IIb. A minimum of three independent
experiments was done for each enzyme variant; for each protein
concentration 12 readings were taken over 99 seconds and
averaged. The average anisotropy readings were plotted versus
protein concentration, and the resultant curves analysed to give
dissociation constants (KD) and maximum anisotropy indicating
the maximal binding (Bmax). The measured values are shown in
Table 1 and Figure 2.
The KD of full length topoisomerase IIb was found to 72.9 nM
which while lower than that of full length topoisomerase IIa at
189 nM (implying stronger binding), is not a significant difference,
with a p value of 0.0542 by Student’s t-test. There was no
significant difference in binding strength between the full length
and truncated versions of topoisomerase IIa. The difference in KD
between truncated topoisomerase IIb and the other isoforms is
more striking, with truncated topoisomerase IIb having a KD of
18 nM, showing more than 6 times stronger binding than
truncated topoisomerase IIa which has a KD of 116 nM
(p,0.0001). Additionally, truncated topoisomerase IIb gave
significantly stronger binding than the full length version, with a
p value of 0.0189 by Student’s t-test. Our unpublished data with 3
other 40 bp oligonucleotides and all four proteins confirmed that
truncated topoisomerase IIb bound most strongly.
No significant difference was seen in maximal binding for the
full length topoisomerase IIa, the full length topoisomerase IIb or
the C-terminally truncated topoisomerase IIa, their Bmax values
being 0.215, 0.268 and 0.229 respectively. However the Bmax of
the truncated topoisomerase IIb at 0.173 was significantly lower
than either the full length topoisomerase IIb (p = 0.0002) or the
truncated topoisomerase IIa (p = 0.0045), suggesting that the lack
of the topoisomerase IIb C-terminal domain significantly alters the
Topoisomerase II
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e14693
maximal binding of this protein. While it is not possible to
ascertain specific mechanistic details from this data, the lower
Bmax of truncated topoisomerase IIb indicates that this enzyme
has a different mode of binding to the DNA substrate, in addition
to the stronger binding shown by lower KD, when compared with
the other isoforms.
Strand Passage of human topoisomerase II with different
metals
Previous work with E. coli gyrase has shown that Ca2+, Mn2+
and Co2+, in addition to Mg2+, can support the strand passage
reaction [15], in contrast to D. Melanogaster topoisomerase II where
only Mg2+ could support strand passage [16], indicating that there
may be species specific differences in this regard. Strand passage
by full length and C-terminally truncated topoisomerase IIa and
topoisomerase IIb was investigated using Mg2+, Ca2+, Mn2+, Co2+
and Ni2+ as potential supporting ions. For all four proteins the
degree of strand passage varied with supporting ion. Figure 3 and
Table 2 show the average decatenation of full length and
truncated isoforms in the presence of magnesium, calcium or
manganese. In each case decatenation with magnesium was set to
100% and that with calcium and manganese is expressed relative
to this. In all cases the preference of ions for strand passage was
similar; greatest decatenation was found with magnesium, then
calcium, and then manganese, an order that is consistent with the
results reported with E. coli gyrase [15]. Nickel and cobalt
supported no detectable strand passage under the conditions used
here.
The significance of the degree of activity relative to that with
magnesium was assessed using a one-sample t-test measuring
Figure 2. Binding of full length and C-terminally truncated topoIIa and topoIIb to a 40 bp DNA oligo. (A) Typical anisotropy curve,
measuring topoisomerase IIb binding to oligo AB. (B) KD of binding (in nM). (C) Maximum anisotropy (Bmax). The average of at least three
independent experiments is shown with error bars representing standard error from the mean. Statistical significance is indicated with * representing
p,0.05, ** representing p,0.01 and *** representing p,0.001.
doi:10.1371/journal.pone.0014693.g002
Table 1. Binding of full length and C-terminally truncated
topoIIa and topoIIb to a 40 bp DNA oligo, showing binding
affinity (KD) and maximum anisotropy (Bmax).
KD (nM) Bmax
Topoisomerase IIa 189657.4 0.215660.034
Topoisomerase IIb 72.9618.6 0.267960.013
Truncated topoisomerase IIa 116.363.48 0.229260.0016
Truncated topoisomerase IIb 17.862.72 0.172660.0069
The average of at least three independent experiments is shown with standard
error from the mean indicated.
doi:10.1371/journal.pone.0014693.t001
Topoisomerase II
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variance from 100%. Manganese supported significantly less
decatenation than that of magnesium when topoisomerase IIb
(p = 0.0379), truncated topoisomerase IIa (p = 0.0005) and trun-
cated topoisomerase IIb (p = 0.0351) were considered. Consider-
ing calcium, only truncated topoisomerase IIb gave significantly
less decatenation than with magnesium (p= 0.0142). There was no
significant difference in the relative response to metals by isoform
or upon removing the C-terminal domain.
DNA binding to 40 bp oligo in the presence of metal ions
The level of strand passage by topoisomerase IIa and
topoisomerase IIb varies significantly with supporting metal ion
(above). To determine whether this was due to differences in
interaction strength with DNA, the interaction of human
topoisomerase IIa or topoisomerase IIb with the 40 bp DNA
oligo described above, in the absence of ions as well as the
presence of magnesium or calcium ions, was assessed.
Data are shown in Figure 4 and Table 3. The DNA binding
affinity of neither topoisomerase IIa nor topoisomerase IIb is
significantly altered by the presence of magnesium or calcium, as
seen previously by gel mobility shift assay [39]. As above, in all
cases the topoisomerase IIa protein binds to the oligo less strongly
than the topoisomerase IIb protein. In the absence of metal ions,
topoisomerase IIa binds with an affinity of 160.5649.7 nM, while
topoisomerase IIb binds with an affinity of 46.4618.1 nM, a
difference that is statistically significant (p = 0.0276). In the
presence of magnesium ions topoisomerase IIa binds with an
affinity of 150.3665.0 nM, and topoisomerase IIb with an affinity
of 55.4610.7 nM, a difference that is also statistically significant
(p = 0.0401). While topoisomerase IIa binds less strongly, again,
than topoisomerase IIb in the presence of calcium ions, with KDs
of 177.7690.9 and 84.3619.5 respectively (p = 0.2867), the
difference did not reach significance with 3 replicates.
Discussion
We have used fluorescence anisotropy to investigate the DNA
interaction between the two human topoisomerase II isoforms,
and the impact of the C-terminal domain on this interaction.
Firstly, the relative binding affinities of topoisomerase IIa and b,
Figure 3. Relative decatenation of full length and C-terminally
truncated topoIIa or topoIIb with different supporting metal
ions. Mg – Magnesium, Ca – Calcium, Mn – Manganese. For each
protein, strand passage with magnesium ions was taken as 100% and
other values calculated relative to this. The average of at least two
independent experiments is shown, with error bars representing
standard error from the mean. Statistical significance is indicated with
* representing p,0.05 and *** representing p,0.001.
doi:10.1371/journal.pone.0014693.g003
Table 2. Relative decatenation of full length or C-terminally
truncated topoIIa or topoIIb with magnesium (Mg2+), Calcium
(Ca2+) or Manganese (Mn2+) as supporting ion.
Mg2+ Ca2+ Mn2+
Topoisomerase IIa 100 46.12627.9 13.91613.91
Topoisomerase IIb 100 46.59640.02 13.5965.16
Truncated topoisomerase
IIa
100 40.07615.25 3.4162.08
Truncated topoisomerase
IIb
100 24.969.05 16.14616.14
For each protein, strand passage with magnesium ions was taken as 100% and
other values calculated relative to this. The average of at least two independent
experiments is shown, with standard error from the mean indicated.
doi:10.1371/journal.pone.0014693.t002
Figure 4. The KD of binding to oligo AB (in nM) of full length
topoIIa and topoIIb, in the absence of metal or the presence of
magnesium (Mg) or calcium (Ca) ions. The average of at least two
independent experiments is shown, with error bars representing
standard error from the mean.
doi:10.1371/journal.pone.0014693.g004
Table 3. The KD of binding of topoIIa or topoIIb (in nM) to
DNA with no metal, 10 mM MgCl2, or 10 mM CaCl2.
KD TopoIIa (nM) KD TopoIIb (nM)
No metal 160.5649.66 46.35618.09
10 mM MgCl2 150.3665.01 55.39610.7
10 mM CaCl2 177.7690.89 84.33619.45
The average of at least two independent experiments is shown with standard
error of the mean indicated.
doi:10.1371/journal.pone.0014693.t003
Topoisomerase II
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both full length and C-terminally truncated, were assessed using a
40 bp oligo with an mAMSA cleavage site that has been used
previously in DNA binding studies [35,39–40]. The KD of binding
determined by fluorescence anisotropy was comparable to that
found by gel mobility shift analysis on the same oligonucleotide
substrate (130 nM) [39], but differed from that found by surface
plasmon resonance (SPR – 1.73 nM) [40]. SPR differs from the
first two assays in that the DNA substrate is fixed a one end, so
reducing its ability to diffuse away from the protein, which may
account for the difference in KD seen.
Topoisomerase IIb, whether full length or C-terminally
truncated, gave stronger binding than its topoisomerase IIa
counterpart, suggesting topoisomerase IIb binds DNA with higher
affinity, consistent with isoform specific DNA interactions [29–30].
The anisotropy data is most striking when the truncated
topoisomerase IIb isoform is considered, this having significantly
lower maximum anisotropy than the other three isoforms. When
three other oligonucleotides were tested truncated topoisomerase
IIb had the strongest binding of all four enzyme isoforms
(unpublished data). The significantly stronger binding of topo-
isomerase IIb once the C terminal domain is removed supports the
idea that the C-terminal domain may act as a negative regulator of
DNA interaction, and that this could provide a rationale for
isoform specific functions in vivo [33].
Metal ions are needed in the strand passage reaction both to
coordinate ATP for hydrolysis and to polarise the active site
tyrosine before the cleavage reaction. Work reported previously
indicated that D. Melanogaster topoisomerase II could only perform
strand passage in the presence of magnesium ions [16], in contrast
to work with bacterial gyrase which showed that magnesium,
calcium, manganese and cobalt ions could all support strand
passage [15]. We show that magnesium, calcium and manganese
ions can all support the strand passage reaction in human
topoisomerase IIs, to varying degrees, in an order consistent with
previous work [15]. We found no evidence that cobalt ions could
support the strand passage reaction of human topoisomerase IIs, in
contrast to an earlier report [41]. The reason for this difference is
unknown, but could be related to the metal salt forms used –
Baldwin et al. use the chloride salt form, whereas the sulphate
form was used in this case. Interestingly cobalt, but not
magnesium, calcium or manganese, supported cleavage of the
topoisomerase IIb enzyme using a metal affinity cleavage assay
based on Fenton chemistry [42] (unpublished data). No cobalt was
found to be associated with either topoisomerase IIa or IIb when
an elemental profile was established using Inductively Coupled
Plasma Mass Spectrometry (ICP-MS), although interestingly zinc
was found to be consistently associated with both isoforms using
this technique (unpublished data).
The strength of interaction of topoisomerase IIa or topoisom-
erase IIb with DNA wasn’t affected by the presence of magnesium
or calcium ions, indicating that the difference in the level of strand
passage supported by different ions may be due to differences in
their ability to support the phosphoryl-transfer reaction of
cleavage, rather than differences in DNA substrate interaction.
The presence or absence of the C-terminal domain of either
isoform had no effect on the relative levels of strand passage with
each protein, indicating that the C-terminal domain is not
involved in the co-ordination of metal ions for strand passage.
This is consistent with the proposed location of the metal ion
binding sites in the B’ region of the core of the enzyme [15,18–19],
and recent topoisomerase II-DNA structures [20–22,24].
In conclusion, we have shown that the C-terminal domain of
topoisomerase IIb, but not topoisomerase IIa, has a significant
effect on the KD with DNA, providing further evidence that this
region of topoisomerase IIb may have a negative regulatory role
[33].
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